FDA Enforcement
Class II
Ongoing
CMV IgM EIA, in vitro diagnostic.
Recall: Z-0342-2023
·
Reported December 7, 2022
Enforcement
- Recall Number
- Z-0342-2023
- Event ID
- 91106
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Bio-Rad Laboratories, Inc.
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- December 7, 2022
- Initiation Date
- October 19, 2022
- Classification Date
- November 30, 2022
- Address
- 6565 185th Ave Ne, Redmond, WA, 98052-5039, United States
Description
CMV IgM EIA, in vitro diagnostic.
Reason
Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).
Code Info
Catalog Number: 25178 UDI-DI Code: 00847865010733 Lot Numbers: B02022 E10022 G05022
Distribution
U.S.: CA, CO, FL, GA, HI, IA, MA, MN, NC, NH, NJ, PA, TN, and TX O.U.S.: None
Quantity
180 kits